Title: Prevention of Preterm Labour in High Risk Woman by Vaginally Administered Natural Micronized Progesterone in Tertiary Care Hospital at Muzaffarpur, Bihar

Authors: Dr Gaurav Tiwary, Dr Ashish Ranjan, Dr G.P.Singh, Dr Deepak Kumar, Dr Satyendra Pathak

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i6.134

Abstract

Objective: A Prospective study to evaluate the effect of Prophylactic administration of natural micronized progesterone vaginally, on the occurrence of spontaneous Preterm birth in high risk woman.

Materials and Methods: A total of 60 Pregnant woman attending the GOPD and all women fulfilling inclusion criteria were examined thoroughly. Half of the women under the study received 200mg natural micronized progesterone per vaginally twice daily. The treatment continued up to 36 weeks of gestation if not delivered earlier. Another half did not receive any progesterone supplement and this group served as control. Finally incidence of preterm labour among both the groups were compared.

Results: Incidence of preterm delivery was significantly low in those receiving vaginal natural micronized progesterone than those who did not receive.

Conclusion: Vaginally administered natural micronized progesterone was found beneficial for mothers with past history of spontaneous preterm labour.

Keywords: Preterm labour, natural micronized progesterone.

References

  1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births : final data for 2002. National Vital Statistics Report 2003;52 (10): 1-113.
  2. Elder DE, Haga R, Evans SF, Benninger HR, French NP. Hospital admission in the first year of life in very preterm infacnts. Journal of Paediatrics & Child Health 1999;35(2):145-50.
  3. Hack M. Consideration of the use of health status, functional outcome & quality-of-life to monitor neonatal intensive care practice. Paediatrics 1999;103(1 Suppl E): 319-28.
  4. Carr-Hill RA, Hall MH. The repetition of spontaneous preterm labour. BJOG: an international journal of obstetrics & gynaecology 1985;92:921-8.
  5. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth (Review). dodd jm, flenady v. cincotta r, crowther ca (the cochrane collaboration)
  6. The new england journal of medicine : Original article- Progesterone & the risk of preterm birth among women witha short cervix-Eduardo B. Fonseca & Colleagues.
  7. *da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. American Journal of Obstetrics & Gynaecology 2003;188 (2):419-24.—'da Fonseca EB, Bittar RE, Carvalho MHB, martinelli S, Zugaib M. Uterine contraction monitoring in pregnant women using vaginal natural progesterone. Journal of Perinatal Medicine 2001;29 Supple (Pt 2):525.
  8. sharecare.com/question/what is micronized natural progesterone.
  9. Progesterone for prevention of preterm birth in twin pregnancy (STOPPIT): a randomized, double-blind, placebo-controlled study & metaanalysis-Jane E Norman and associates.
  10. Vaginal micronized progesterone & risk of preterm delivery in high risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial & meta-analysis-K. Klein and associates-Dept. of Obst. & Gynae., Medical University of Vienna.

Corresponding Author

Dr Deepak Kumar

Associate Professor, Department of Pharmacology

Sri Krishna Medical College, Muzaffarpur